logo

Hanall is at the forefront of revolutionizing lives through an exceptional range of pharmaceutical products. Our extensive expertise encompasses various fields
such as endocrine, circulatory, and urologic diseases. By demonstrating a profound understanding of immunology, we have propelled ourselves into new
territories, broadening our focus to include ophthalmology, immunology, oncology, and neurology.

We strive to deliver first-in-class and best-in-class therapeutics to meet the unmet medical needs of patients through the advancement of science. We pursue
innovation through strong ethical considerations and a performance, collaborative oriented culture. Our successful development of multiple therapeutics from
discovery through submission is driven by investing in strong protein development resources. In accordance with our vision, we have committed to our
innovation, successful partnerships, and investments in the artificial intelligence (AI) space.

HanAll has secured a robust pipeline with the potential to expand into a diverse number of
diseases in oncology, immunology, neurology and ophthalmology.
Our therapies are expected to overcome the limitations of existing products and ultimately
change patients’ lives.